AG2R LA Mondiale Gestion D Actifs raised its position in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 117,914 shares of the company’s stock after buying an additional 447 shares during the quarter. Procter & Gamble accounts for 1.0% of AG2R LA Mondiale Gestion D Actifs’ portfolio, making the stock its 17th largest position. AG2R LA Mondiale Gestion D Actifs’ holdings in Procter & Gamble were worth $18,786,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC boosted its stake in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Northern Trust Corp boosted its position in shares of Procter & Gamble by 0.8% in the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares during the period. Price T Rowe Associates Inc. MD grew its holdings in shares of Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. raised its position in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after buying an additional 583,629 shares during the period. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after acquiring an additional 1,018,865 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several research firms have weighed in on PG. Wells Fargo & Company lowered their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a research note on Thursday, September 25th. UBS Group lowered their price objective on shares of Procter & Gamble from $180.00 to $176.00 and set a “buy” rating on the stock in a research report on Wednesday, October 8th. Raymond James Financial dropped their price objective on shares of Procter & Gamble from $185.00 to $175.00 and set an “outperform” rating on the stock in a research note on Monday, October 20th. Berenberg Bank lifted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a research note on Wednesday, September 17th. Finally, Barclays lowered their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $171.68.
Procter & Gamble Price Performance
NYSE PG opened at $152.62 on Friday. The company has a 50 day moving average price of $154.66 and a two-hundred day moving average price of $158.41. Procter & Gamble Company has a 12-month low of $146.96 and a 12-month high of $180.43. The stock has a market capitalization of $357.21 billion, a PE ratio of 23.44, a price-to-earnings-growth ratio of 4.04 and a beta of 0.36. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. The business had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. Procter & Gamble’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter last year, the firm earned $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Stockholders of record on Friday, October 24th will be issued a dividend of $1.0568 per share. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble’s dividend payout ratio is currently 64.98%.
Insider Buying and Selling
In other Procter & Gamble news, CEO Jon R. Moeller sold 40,119 shares of the company’s stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the completion of the sale, the chief executive officer directly owned 319,375 shares in the company, valued at $50,228,106.25. This represents a 11.16% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary A. Coombe sold 10,194 shares of the firm’s stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the sale, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by corporate insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- How to Use Stock Screeners to Find Stocks
- Time to Take Notice: PEGA’s GenAI Blueprint Delivers Huge Q3 Beat
- Stock Average Calculator
- MarketBeat Week in Review – 10/20 – 10/24
- What is the S&P 500 and How It is Distinct from Other Indexes
- Rayonier-PotlatchDeltic Merger Signals Industry Upside
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
